These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19689329)

  • 1. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?
    Korostenskaja M; Kähkönen S
    Curr Pharm Des; 2009; 15(22):2573-93. PubMed ID: 19689329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clozapine on auditory event-related potentials in schizophrenia.
    Umbricht D; Javitt D; Novak G; Bates J; Pollack S; Lieberman J; Kane J
    Biol Psychiatry; 1998 Oct; 44(8):716-25. PubMed ID: 9798075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy.
    Oranje B; Aggernaes B; Rasmussen H; Ebdrup BH; Glenthøj BY
    Psychol Med; 2017 Sep; 47(12):2155-2165. PubMed ID: 28443529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do high or low doses of anxiolytics and hypnotics affect mismatch negativity in schizophrenic subjects? An EEG and MEG study.
    Kasai K; Yamada H; Kamio S; Nakagome K; Iwanami A; Fukuda M; Yumoto M; Itoh K; Koshida I; Abe O; Kato N
    Clin Neurophysiol; 2002 Jan; 113(1):141-50. PubMed ID: 11801436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.
    Javitt DC; Doneshka P; Grochowski S; Ritter W
    Arch Gen Psychiatry; 1995 Jul; 52(7):550-8. PubMed ID: 7598631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders.
    Korostenskaja M; Dapsys K; Siurkute A; Maciulis V; Ruksenas O; Kähkönen S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):543-8. PubMed ID: 15866356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.
    Bravermanová A; Viktorinová M; Tylš F; Novák T; Androvičová R; Korčák J; Horáček J; Balíková M; Griškova-Bulanova I; Danielová D; Vlček P; Mohr P; Brunovský M; Koudelka V; Páleníček T
    Psychopharmacology (Berl); 2018 Feb; 235(2):491-503. PubMed ID: 29302713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.
    Zhou Z; Zhu H; Chen L
    PLoS One; 2013; 8(1):e52186. PubMed ID: 23308105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
    Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
    Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between auditory processing and affective prosody in schizophrenia.
    Jahshan C; Wynn JK; Green MF
    Schizophr Res; 2013 Feb; 143(2-3):348-53. PubMed ID: 23276478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
    Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant electroconvulsive therapy with antipsychotics is associated with improvement in auditory mismatch negativity in schizophrenia.
    Liu Y; Jia LN; Wu H; Jiang W; Wang Q; Wang D; Xiong YB; Ren YP; Ma X; Tang YL
    Psychiatry Res; 2022 May; 311():114484. PubMed ID: 35245745
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
    Javitt DC; Steinschneider M; Schroeder CE; Arezzo JC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11962-7. PubMed ID: 8876245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication.
    Kruiper C; Glenthøj BY; Oranje B
    Neuropsychopharmacology; 2019 May; 44(6):1062-1067. PubMed ID: 30797222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia.
    Dunn W; Rassovsky Y; Wynn JK; Wu AD; Iacoboni M; Hellemann G; Green MF
    Schizophr Res; 2016 Jul; 174(1-3):189-191. PubMed ID: 27132485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.
    Leung S; Croft RJ; Baldeweg T; Nathan PJ
    Psychopharmacology (Berl); 2007 Nov; 194(4):443-51. PubMed ID: 17611739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of lamotrigine in schizophrenia.
    Large CH; Webster EL; Goff DC
    Psychopharmacology (Berl); 2005 Sep; 181(3):415-36. PubMed ID: 16001126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
    Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
    Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.